News Quantified

RVMD – revolution medicines, inc. (US:NASDAQ)

Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.

1/19

07:26 pm

rvmd

Low

Janus Henderson Enterprise Fund Q4 2025 Commentary [Seeking Alpha]

On biotech's biggest stage, renewed excitement gets a stress test [Yahoo! Finance]

Revolution Medicines (NASDAQ:RVMD) was given a new $143.00 price target on by analysts at Mizuho.

JPM 26: Day 1 – drug prices and policy changes drive the agenda [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}